Skip to main content
. 2013 Apr 6;138(3):829–837. doi: 10.1007/s10549-013-2447-8

Fig. 1.

Fig. 1

Overall response rate. DFI disease-free interval, Doc docetaxel, nab-P nab-paclitaxel, ORR overall response rate, P paclitaxel, q3w every 3 weeks, qw 3/4 the first 3 of 4 weeks